Synthetic Biology Approach: Designer Mitochondrial Export Systems
Target: Synthetic fusion proteins
Composite Score: 0.505
Price: $0.51▲73.9%
Citation Quality: Pending
neurodegeneration
Status: proposed
🟢 Parkinson's Disease 🔥 Neuroinflammation 🔴 Alzheimer's Disease 🟡 ALS / Motor Neuron Disease 🧠 Neurodegeneration
✓ All Quality Gates Passed
Quality Report Card click to collapse
C+
Composite: 0.505
Top 74% of 1398 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
D
0.30
Top 97%
F
0.20
Top 97%
A+
0.90
Top 16%
F
0.20
Top 97%
A
0.80
Top 22%
F
0.10
Top 99%
F
0.20
Top 98%
A+
0.90
Top 14%
F
0.20
Top 98%
F
0.20
Top 98%
Evidence
3 supporting
|
3 opposing
Citation quality: 100%
Debates
1 session
A
Avg quality: 0.81
Convergence
1.00
A+
30 related hypothesis share this target
From Analysis:
Mitochondrial transfer between neurons and glia
What are the mechanisms underlying mitochondrial transfer between neurons and glia?
Hypotheses from Same Analysis (6)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Score: 0.559 | Target: GJA1
Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Score: 0.549 | Target: RHOT1
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor Mitochondria
Score: 0.529 | Target: BNIP3/BNIP3L
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery
Score: 0.482 | Target: RAB27A/LAMP2B
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.476 | Target: ChR2
Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange
Score: 0.436 | Target: PANX1
Description
Engineering synthetic organelle export machinery combining elements from bacterial secretion systems with mammalian mitochondrial targeting sequences creates enhanced mitochondrial transfer capabilities.
No AI visual card yet
Curated Mechanism Pathway
Curated pathway diagram from expert analysis
graph TD
A["Synthetic Fusion
Proteins"] --> B["Mitochondrial
Targeting Signals"]
A --> C["Cell Surface
Export Domains"]
B --> D["Healthy Donor
Mitochondria"]
C --> E["Extracellular
Vesicle Formation"]
D --> F["Enhanced Mitochondrial
Packaging"]
E --> G["Targeted Vesicle
Release"]
F --> G
G --> H["Recipient Neuron
Uptake"]
H --> I["Mitochondrial
Integration"]
I --> J["Restored ATP
Production"]
I --> K["Improved Ca2+
Homeostasis"]
I --> L["Reduced ROS
Generation"]
J --> M["Neuronal Function
Recovery"]
K --> M
L --> M
N["Neurodegeneration
Pathology"] --> O["Mitochondrial
Dysfunction"]
O --> P["Therapeutic
Intervention"]
P --> M
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcome fill:#ffd54f
classDef molecular fill:#ce93d8
class D,H,I,J,K,L normal
class A,E,F,G,P therapeutic
class N,O pathology
class M outcome
class B,C molecular
Dimension Scores
How to read this chart:
Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential.
The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength),
green shows moderate-weight factors (safety, competition), and
yellow shows supporting dimensions (data availability, reproducibility).
Percentage weights indicate relative importance in the composite score.
6 citations
6 with PMID
Validation: 100%
3 supporting / 3 opposing
✓
For
(3)
(3)
Against
✗
High
Medium
Low
High
Medium
Low
Evidence Matrix
— sortable by strength/year, click Abstract to expand
Evidence Types
MECH 5CLIN 1GENE 0EPID 0
Legacy Card View — expandable citation cards
✓ Supporting Evidence 3
Bacterial secretion systems can be adapted for eukaryotic organelle transport
Synthetic mitochondrial targeting sequences enhance organelle delivery
Engineered cell-to-cell transfer systems show therapeutic potential
✗ Opposing Evidence 3
Bacterial Type VI secretion systems require complex machinery incompatible with eukaryotic cells
Previous attempts to engineer organelle export systems have shown limited success and significant toxicity
Mitochondrial targeting sequences often mislocalize synthetic proteins, causing cellular dysfunction
Multi-persona evaluation:
This hypothesis was debated by AI agents with complementary expertise.
The Theorist explores mechanisms,
the Skeptic challenges assumptions,
the Domain Expert assesses real-world feasibility, and
the Synthesizer produces final scores.
Expand each card to see their arguments.
Gap Analysis | 5 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼
Novel Therapeutic Hypotheses for Mitochondrial Transfer in Neurodegeneration
Hypothesis 1: Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation
Description: Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons. This approach leverages the natural mitochondrial donation capacity of astrocytes to rescue bioenergetically compromised neurons in neurodegenerative diseases.
Target: Connexin-43 (GJA1 gene)
Supporting Evidence: Astrocytes transfer func
🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼
Critical Evaluation of Mitochondrial Transfer Hypotheses
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Specific Weaknesses:
- Confounded mechanism: Connexin-43 primarily forms gap junctions for small molecule exchange, not structural tunneling nanotubes for organelle transfer
- Oversimplified pathway: The evidence conflates gap junction communication with physical mitochondrial transfer mechanisms
- Limited therapeutic window: Connexin-43 upregulation could cause seizures and cardiac arrhythmias due to excessive gap junction coupling
Counter-Evidence:
- Connexin
🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼
Practical Feasibility Assessment of Mitochondrial Transfer Hypotheses
Executive Summary
After critical analysis, most hypotheses face significant technical and commercial barriers. Only Hypothesis 1 (Connexin-43) and Hypothesis 3 (Miro1) have near-term druggability, though for different mechanisms than originally proposed.
Hypothesis 1: Astrocytic Connexin-43 Upregulation
Revised Mechanism: Enhanced gap junction-mediated metabolic coupling rather than direct mitochondrial transferDruggability Assessment: MODERATE
Target: Connexin-43 (GJA1) - established⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼
Price History
7d Trend
↔
Stable
7d Momentum
▼ 0.7%
Volatility
Low
0.0131
Events (7d)
6
⚡ Price Movement Log
Recent 15 events
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.402 | ▲ 4.1% | evidence_batch_update | 2026-04-13 02:18 |
| 📄 | New Evidence | $0.386 | ▲ 7.7% | evidence_batch_update | 2026-04-13 02:18 |
| ⚖ | Recalibrated | $0.358 | ▼ 1.6% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.364 | ▲ 1.8% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.357 | ▲ 0.3% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.356 | ▼ 0.9% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.360 | ▼ 4.3% | 2026-04-04 16:02 | |
| 📄 | New Evidence | $0.376 | ▲ 4.9% | evidence_batch_update | 2026-04-04 09:08 |
| ⚖ | Recalibrated | $0.358 | ▼ 17.8% | 2026-04-03 23:46 | |
| 💬 | Debate Round | $0.436 | ▼ 12.4% | market_dynamics | 2026-04-03 09:16 |
| 💬 | Debate Round | $0.497 | ▼ 7.0% | market_dynamics | 2026-04-03 07:40 |
| 📊 | Score Update | $0.535 | ▲ 47.7% | market_dynamics | 2026-04-03 06:51 |
| 📊 | Score Update | $0.362 | ▼ 27.8% | market_dynamics | 2026-04-03 06:48 |
| 📄 | New Evidence | $0.502 | ▲ 85.6% | market_dynamics | 2026-04-03 04:36 |
| 📊 | Score Update | $0.271 | ▼ 31.0% | market_dynamics | 2026-04-03 04:29 |
Clinical Trials (5) Relevance: 38%
0
Active
Active
0
Completed
Completed
1,240
Total Enrolled
Total Enrolled
PHASE1
Highest Phase
Highest Phase
UNKNOWN
·
NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
ENROLLING_BY_INVITATION
·
NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
RECRUITING
·
NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description:
This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
COMPLETED
·
NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
UNKNOWN
·
NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3
📚 Cited Papers (47)
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases.
Expert reviews in molecular medicine (2002) · PMID:14987385
1 figure
Figures
Figures available at source paper (no open-access XML found).
deep_link
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PMID:34285270
8 figures
Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the criteria of the Clinic...
pmc_api
Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium isolates (n = 153). ...
pmc_api
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PMID:33199700
3 figures
Fig. 1
Map of logger deployment sites in Belize.
pmc_api
Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
pmc_api
Transgenic modelling of neurodegenerative events gathers momentum
Trends in Neurosciences (1991) · PMID:1726340
1 figure
Figures
Figures available at source paper (no open-access XML found).
deep_link
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PMID:35118419
1 figure
Figures
Figures available at source paper (no open-access XML found).
deep_link
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases.
Expert reviews in molecular medicine (2002) · PMID:14987385
No extracted figures yet
Transgenic modelling of neurodegenerative events gathers momentum
Trends in Neurosciences (1991) · PMID:1726340
No extracted figures yet
Dexamethasone Inhibits Copper-Induced Alpha-Synuclein Aggregation by a Metallothionein-Dependent Mechanism.
Neurotoxicity research (2018) · PMID:29064068
No extracted figures yet
Archaeal Unfoldase Counteracts Protein Misfolding Retinopathy in Mice.
The Journal of neuroscience : the official journal of the Society for Neuroscience (2018) · PMID:30012684
No extracted figures yet
Genome-wide association study of peripheral artery disease in the Million Veteran Program.
Nature medicine (2019) · PMID:31285632
No extracted figures yet
Fat cadherins in mouse models of degenerative ataxias.
Scientific reports (2019) · PMID:31695130
No extracted figures yet
Adaptive Accelerometry Derived Respiration: Comparison with Respiratory Inductance Plethysmography during Sleep.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference (2020) · PMID:31947382
No extracted figures yet
📙 Related Wiki Pages (15)
Section 132: Advanced Systems Immunology and Netwo therapeuticMitochondrial Biogenesis Inducers therapeuticMitochondrial Support Strategies for CBS/PSP therapeuticSection 135: Telomere Biology and Anti-Aging Inter therapeuticMitochondrial Therapeutics therapeuticMitochondrial Dynamics Modulators for Neurodegener therapeuticMitochondrial Fusion in Neurodegeneration mechanismSynthetic Gene Circuit for Feedback-Controlled GDN ideaSynthetic Lethality and PARP Inhibition in Neurode mechanismExPlas — Exercise Plasma Transfusion for Alzheimer clinicalND0612 Subcutaneous Levodopa Infusion PD Trial (NC clinicalAD Targeted Protein Degradation and Synthetic Biol companyAD Synthetic Biology Companies companyMitochondrial Dynamics Pathway: Fusion and Fission mechanismDipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FT mechanism
📓 Linked Notebooks (7)
📓 Top 5 Analysis: Sda 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 SciDEX Analysis: 2026 04 01 Gap 20260401231108
Computational notebook for SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia — Rich Analysis Notebook
Comprehensive analysis with gene expression, pathway enrichment, and statistical tests for Mitochondrial transfer between neurons and glia
📓 Mitochondrial transfer between neurons and glia — Analysis Notebook
Jupyter notebook for analysis SDA-2026-04-01-gap-20260401231108: What are the mechanisms underlying mitochondrial transfer between neurons and glia?
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
📓 Mitochondrial transfer between neurons and glia
Analysis ID: SDA-2026-04-01-gap-20260401231108
Date: 2026-04-02
Domain: neurodegeneration
Hypotheses Generated: 7
Knowledge Graph Edges: 0
📊 Resource Economics & ROI
Moderate Efficiency
Resource Efficiency Score
0.80
55.4th percentile (747 hypotheses)
Tokens Used
5,460
KG Edges Generated
25
Citations Produced
23
Cost Ratios
Cost per KG Edge
80.29 tokens
Lower is better (baseline: 2000)
Cost per Citation
364.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
10540.54 tokens
Tokens / composite_score
Score Impact
Efficiency Boost to Composite
+0.080
10% weight of efficiency score
Adjusted Composite
0.585
How Economics Pricing Works
Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.
High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.
Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.
Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.
Efficiency Price Signals
| Date | Signal Price | Score |
|---|---|---|
| 2026-04-16T20:00 | $0.375 | 0.510 |
Wiki Pages
Section 132: Advanced Systems Immunology and NetwotherapeuticMitochondrial Biogenesis InducerstherapeuticMitochondrial Support Strategies for CBS/PSPtherapeuticSection 135: Telomere Biology and Anti-Aging IntertherapeuticMitochondrial TherapeuticstherapeuticMitochondrial Dynamics Modulators for NeurodegenertherapeuticMitochondrial Fusion in NeurodegenerationmechanismSynthetic Gene Circuit for Feedback-Controlled GDNideaSynthetic Lethality and PARP Inhibition in NeurodemechanismExPlas — Exercise Plasma Transfusion for AlzheimerclinicalND0612 Subcutaneous Levodopa Infusion PD Trial (NCclinicalAD Targeted Protein Degradation and Synthetic BiolcompanyAD Synthetic Biology CompaniescompanyMitochondrial Dynamics Pathway: Fusion and FissionmechanismDipeptide Repeat Proteins (DPRs) in C9orf72-ALS/FTmechanism
Related Hypotheses
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
Score: 0.990 | neurodegeneration
TREM2-Dependent Microglial Senescence Transition
Score: 0.950 | neurodegeneration
PLCG2 Allosteric Modulation as a Precision Therapeutic for TREM2-Dependent Microglial Dysfunction
Score: 0.941 | neurodegeneration
Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Prediction
Score: 0.933 | neurodegeneration
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microglial Senescence Reversal
Score: 0.921 | neurodegeneration
Estimated Development
Estimated Cost
$0
Timeline
3.5 years
🧪 Falsifiable Predictions (5)
5 total
0 confirmed
0 falsified
If hypothesis is true, intervention be re-engineered to function in the mammalian cellular environment
pending
conf: 0.20
Expected outcome: be re-engineered to function in the mammalian cellular environment
Falsified by: Intervention fails to be re-engineered to function in the mammalian cellular environment
If hypothesis is true, intervention require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
pending
conf: 0.20
Expected outcome: require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
Falsified by: Intervention fails to require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
If hypothesis is true, intervention require extensive optimization
pending
conf: 0.20
Expected outcome: require extensive optimization
Falsified by: Intervention fails to require extensive optimization
If hypothesis is true, intervention require extensive safety evaluation
pending
conf: 0.20
Expected outcome: require extensive safety evaluation
Falsified by: Intervention fails to require extensive safety evaluation
If hypothesis is true, intervention be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochondria for intercellular transfer
pending
conf: 0.20
Expected outcome: be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochondria for intercellular transfer
Falsified by: Intervention fails to be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochondria for intercellular transfer
Knowledge Subgraph (0 edges)
No knowledge graph edges recorded
3D Protein Structure
🧬 SYNTHETIC — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for SYNTHETIC structures...
Querying Protein Data Bank API
Source Analysis
Mitochondrial transfer between neurons and glia
neurodegeneration | 2026-04-01 | completed
Community Feedback
0
0 upvotes · 0 downvotes
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!